BDC 2012 - 2nd Biomarker Discovery Conference
Date2012-12-03 - 2012-12-06
Deadline2012-08-18
VenueShoal Bay, Australia
Keywords
Websitehttps://bdc.mtci.com.au/
Topics/Call fo Papers
The 21st century has seen a revolution in biology and medicine that will radically change the way we monitor health and diagnose disease. Central to this revolution: a multidisciplinary approach to the evolving science of biomarker discovery and identification. BDC 2012 showcases the latest innovations in Biomarker Discovery using genomic, proteomic and metabolomic tools and methods.
BDC 2012 Themes and Topics:
Molecular Signature
Molecular Diagnostics
Personalised Medicine
Information-based Medicine
P4 Medicine (Predictive, Preventive, Personalised and Participatory)
Computational biomarker discovery in Proteomics
The Business of Biomarkers: Ethical, Regulatory, Economical
Clinical Bioinformatics and Translational Medicine
Synthetic biology
Cancer
Neurobiology and Microbiology
Metabolomics and Pharmacogenomics
Biomarkers in clinical drug development
Safety biomarkers
Methodologies for genome-wide association studies
Computational techniques for patient cohort stratification and segmentation
Deep sequencing
High-throughput technologies
Imaging applications
Supercomputing to identify biomarkers
Mathematical methods for diagnostic classifiers
Biological Network Analysis
Network-based and Pathway-aware biomarker strategies
This conference aims to bring together the major innovators in Scientific research as well as the Research and Development innovators in the most technologically advanced companies in the field. With this in mind, there are new programs for Exhibitors in the Program.
BDC 2012 Themes and Topics:
Molecular Signature
Molecular Diagnostics
Personalised Medicine
Information-based Medicine
P4 Medicine (Predictive, Preventive, Personalised and Participatory)
Computational biomarker discovery in Proteomics
The Business of Biomarkers: Ethical, Regulatory, Economical
Clinical Bioinformatics and Translational Medicine
Synthetic biology
Cancer
Neurobiology and Microbiology
Metabolomics and Pharmacogenomics
Biomarkers in clinical drug development
Safety biomarkers
Methodologies for genome-wide association studies
Computational techniques for patient cohort stratification and segmentation
Deep sequencing
High-throughput technologies
Imaging applications
Supercomputing to identify biomarkers
Mathematical methods for diagnostic classifiers
Biological Network Analysis
Network-based and Pathway-aware biomarker strategies
This conference aims to bring together the major innovators in Scientific research as well as the Research and Development innovators in the most technologically advanced companies in the field. With this in mind, there are new programs for Exhibitors in the Program.
Other CFPs
Last modified: 2012-08-07 22:13:10